Jiyun Shi

Title: The Innovative Contributions of Jiyun Shi

Introduction

Jiyun Shi is a prominent inventor based in Beijing, China. He has made significant strides in the field of pharmacology, particularly in the development of targeted radiopharmaceuticals for tumor treatment. His work is crucial in advancing cancer therapies and improving patient outcomes.

Latest Patents

Jiyun Shi holds a patent for a targeted radiopharmaceutical designed for tumor imaging and treatment. The patent, titled "Targeted radiopharmaceutical for tumor and its use in the imaging-guided combination therapy of targeted radiotherapy and immunotherapy," describes a pharmacological composition that includes a structurally modified RGD polypeptide complexed with a radionuclide. This innovative composition is particularly useful for diagnosing and treating integrin αvβ3-positive tumors. The patent also outlines the potential for combining this treatment with immunotherapeutic agents, enhancing the efficacy of cancer therapies.

Career Highlights

Jiyun Shi is associated with Beijing Giluntide Pharmaceutical Co., Ltd., where he continues to contribute to groundbreaking research in cancer treatment. His work has garnered attention for its potential to revolutionize how tumors are diagnosed and treated, particularly through the integration of radiotherapy and immunotherapy.

Collaborations

Jiyun Shi collaborates with notable colleagues, including Fan Wang and Hannan Gao. Their combined expertise fosters an environment of innovation and progress in the pharmaceutical field.

Conclusion

Jiyun Shi's contributions to the field of targeted radiopharmaceuticals exemplify the potential of innovative therapies in cancer treatment. His work not only advances scientific knowledge but also holds promise for improving patient care in oncology.